1. Academic Validation
  2. Activation of calcium signaling in human gingival fibroblasts by recombinant Porphyromonas gingivalis RgpB protein

Activation of calcium signaling in human gingival fibroblasts by recombinant Porphyromonas gingivalis RgpB protein

  • Eur J Oral Sci. 2019 Aug;127(4):287-293. doi: 10.1111/eos.12622.
Shenglai Li 1 Diya Zhang 2 Kexin Lu 3 Yanmin Wu 3 Lieping Sheng 2 Qi Tang 3
Affiliations

Affiliations

  • 1 Department of Oral and Maxillofacial Surgery, Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • 2 Dental Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • 3 Department of Oral Medicine, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Abstract

Arginine-specific cysteine proteinases, such as Arg-gingipain B (RgpB), mediate inflammation by activating protease-activated receptors (PARs). Arg-gingipain B is produced by Porphyromonas gingivalis, and is implicated in the causation of periodontal disease. The purpose of the present study was to observe the influence of recombinant RgpB protein (rRgpB) on PAR activation by monitoring intracellular Ca2+ ion concentration ([Ca2+]i) and inositol-1,4,5-triphosphate (IP3) levels in human gingival fibroblasts (HGFs). Our findings showed that rRgpB could cause a transient increase in [Ca2+]i. This increase in [Ca2+]i was completely suppressed by vorapaxar, a PAR-1 antagonist. Recombinant Arg-gingipain B increased the concentration of IP3, reaching a maximum at 60 s after treatment; this was completely inhibited by vorapaxar. We therefore conclude that rRgpB-induced calcium signaling in HGFs is mainly caused by PAR-1 activation. This suggests that PAR-1 activation plays a significant role in chronic inflammatory periodontal disease induced by P. gingivalis RgpB.

Keywords

Arg-gingipain B; inositol-1,4,5-triphosphate; intracellular Ca2+ concentration; periodontal disease; protease-activated receptor.

Figures
Products